Navigation Links
Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
Date:11/4/2008

SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ Medizone International, Inc. (Pink Sheets: MZEI) announces the establishment of a strategic consulting relationship with TDV Global, Inc. (TDVGlobal.com). TDV Global is a highly professional and experienced strategic management consulting firm. Approximately 70% of their business involves consulting for government agencies and projects, the remainder for private enterprise, mostly in the Health and Security Medical fields. TDV Global has assisted Medizone with the founding of its recently established non-profit affiliate, The Canadian Foundation for Global Health (CFGH). Mr. Brad Goble, the President of TDV Global, has been appointed an officer and member of the Board of Directors of the Canadian Foundation for Global Health. Additionally, the offices for the CFGH are being located at TDV Global in Ottawa. Working with Dr. Michael E. Shannon of Medizone International, TDV Global has also played a key role in producing the product development plan for Medizone's Hospital Sterilization Initiative.

Edwin Marshall, Chairman of the Board and CEO of Medizone commented, "Over the past ten years, Dr. Shannon has successfully worked on many different projects with Mr. Goble and his firm. Between the Hospital Sterilization Initiative and founding the CFGH, Medizone has been working with TDV Global since mid-September. I could not be more pleased with the results so far. Given their many current health related activities involving G-8 countries, TDV will assist Medizone in strategically aligning us with government and institutional interests in Canada, the US and Europe. We welcome TDV Global as a vital and strategic partner."

Medizone International, Inc., is a research and development stage company engaged in the development of patented and unpatented technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to decontaminate and sterilize hospital surgical suites, emergency rooms and intensive care units.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Web site: http://www.medizoneint.com

Investor Relations 800-953-3350


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
2. Chindex International, Inc. Announces Appearances at Additional November Conferences
3. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
4. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
5. China Yingxia International, Inc. to Promote Benefits of Its Soy Milk Products Over Scandal-Stricken Cows Milk in China
6. Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products
7. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
8. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
9. WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air
10. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
11. Chindex International, Inc. Announces CDC Contract Signing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... Macomb, Michigan (PRWEB) , ... ... ... report published by CBC News on April 4th, 2016 questioned the use ... organization referred to EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally ...
(Date:4/29/2016)... ... 2016 , ... World Patent Marketing , a vertically ... automotive invention that improves the storage features of a pick up truck. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Over the next five ...
(Date:4/29/2016)... MA (PRWEB) , ... April 29, 2016 , ... ... the Two Ten Footwear Foundation, the national charitable foundation serving the footwear industry, ... With 8,000 volunteers representing more than 130 companies across 23 states during the ...
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. ... of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death ... podcasted thereafter . Dr. Bernie Siegel, author of a plethora of essential ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... April 27, 2016   ... Growth in Recurring Consumable Sales  Clinical sales ... Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, ... sales for the first quarter ended March 31, 2016 ... execution of its commercial strategy. First Quarter ...
Breaking Medicine Technology: